Patient-Derived Glial Precursor Cell Therapy for Vanishing White Matter Disease (FWF)

Generation of Improved Cellular and Animal Models for Identification of Disease Phenotype and New Therapeutic Targets of Alzheimer’s Disease (BMWFW)